OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Switch Therapeutics

1 Projects | 1 Researchers | $2,736,900 Invested

2026

Switch Therapeutics

Anindya Bhattacharya, PhD

Developing a novel, conditionally activated siRNA (CASi) molecule for treatment of Alzheimer’s Disease

  • Funding Amount: $2,736,900
  • Organization Type:
  • Program: Drug Discovery
  • Target: ApoE, Lipids and Lipoprotein Receptors
  • Status: Active